[
  {
    "ts": "2025-10-21T16:31:05+00:00",
    "headline": "Analysts Remain Bullish on Peloton Interactive, Inc. (PTON) as Company Balances Revenue Growth and Efficiency",
    "summary": "Coatue Management holds $17.35 million worth of shares in Peloton Interactive, Inc. (NASDAQ:PTON), representing 0.05% of its total 13F portfolio, helping the stock secure a place on our list of billionaire Philippe Laffont’s 10 stock picks with huge upside potential. On October 8, 2025, Truist Securities reiterated its “Buy” rating on Peloton Interactive, Inc. (NASDAQ:PTON) […]",
    "url": "https://finance.yahoo.com/news/analysts-remain-bullish-peloton-interactive-163105582.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "fe0b1dae-2c11-3439-97f9-655dba508e86",
      "content": {
        "id": "fe0b1dae-2c11-3439-97f9-655dba508e86",
        "contentType": "STORY",
        "title": "Analysts Remain Bullish on Peloton Interactive, Inc. (PTON) as Company Balances Revenue Growth and Efficiency",
        "description": "",
        "summary": "Coatue Management holds $17.35 million worth of shares in Peloton Interactive, Inc. (NASDAQ:PTON), representing 0.05% of its total 13F portfolio, helping the stock secure a place on our list of billionaire Philippe Laffont’s 10 stock picks with huge upside potential. On October 8, 2025, Truist Securities reiterated its “Buy” rating on Peloton Interactive, Inc. (NASDAQ:PTON) […]",
        "pubDate": "2025-10-21T16:31:05Z",
        "displayTime": "2025-10-21T16:31:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/504cbefff8fdca8748e0991249e9fd2b",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Analysts Remain Bullish on Peloton Interactive, Inc. (PTON) as Company Balances Revenue Growth and Efficiency",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Yb3TuBbBY9MPY7UwMejTSg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/504cbefff8fdca8748e0991249e9fd2b.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uLrI8bNOxeG_pZJVFrtIRw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/504cbefff8fdca8748e0991249e9fd2b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/analysts-remain-bullish-peloton-interactive-163105582.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/analysts-remain-bullish-peloton-interactive-163105582.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PTON"
            },
            {
              "symbol": "TFC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-21T09:52:58+00:00",
    "headline": "Viatris Inc. (VTRS) Acquires Aculys Pharma, Inc",
    "summary": "​Viatris Inc. (NASDAQ:VTRS) is one of the Best Growth Stocks Under $25 to Buy Right Now. On October 15, Viatris Inc. (NASDAQ:VTRS) announced completing the acquisition of Aculys Pharma, Inc., which is a clinical-stage biopharmaceutical company. ​Aculys Pharma, Inc. is commercializing innovative treatments for neurological conditions. Management noted that, as a result of this acquisition, […]",
    "url": "https://finance.yahoo.com/news/viatris-inc-vtrs-acquires-aculys-095258584.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "ebfa16c9-5450-3fda-9494-dfd97e91f841",
      "content": {
        "id": "ebfa16c9-5450-3fda-9494-dfd97e91f841",
        "contentType": "STORY",
        "title": "Viatris Inc. (VTRS) Acquires Aculys Pharma, Inc",
        "description": "",
        "summary": "​Viatris Inc. (NASDAQ:VTRS) is one of the Best Growth Stocks Under $25 to Buy Right Now. On October 15, Viatris Inc. (NASDAQ:VTRS) announced completing the acquisition of Aculys Pharma, Inc., which is a clinical-stage biopharmaceutical company. ​Aculys Pharma, Inc. is commercializing innovative treatments for neurological conditions. Management noted that, as a result of this acquisition, […]",
        "pubDate": "2025-10-21T09:52:58Z",
        "displayTime": "2025-10-21T09:52:58Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/74fb705bb9c3ce561b1e73c01a8c0ec6",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zGSUgQWY1mvU5iiUFvOJaw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/74fb705bb9c3ce561b1e73c01a8c0ec6.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pOwRcCLvUVYudHrb3ECDAQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/74fb705bb9c3ce561b1e73c01a8c0ec6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/viatris-inc-vtrs-acquires-aculys-095258584.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/viatris-inc-vtrs-acquires-aculys-095258584.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VTRS"
            },
            {
              "symbol": "TFC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-21T09:36:51+00:00",
    "headline": "Truist Raises L3Harris Technologies’ (LHX) Price Target to $353, Maintains Buy Rating",
    "summary": "L3Harris Technologies Inc. (NYSE:LHX) is one of the best defense stocks in Goldman Sachs’ portfolio. On October 15, Truist Securities raised its price target on L3Harris Technologies (NYSE:LHX) to $353 from $302, while maintaining a Buy rating ahead of the sector’s third-quarter earnings season. The firm notes that the demand environment and broader sentiment for the […]",
    "url": "https://finance.yahoo.com/news/truist-raises-l3harris-technologies-lhx-093651659.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "21d7a84a-4824-3cb0-ab3b-151bcf385e2c",
      "content": {
        "id": "21d7a84a-4824-3cb0-ab3b-151bcf385e2c",
        "contentType": "STORY",
        "title": "Truist Raises L3Harris Technologies’ (LHX) Price Target to $353, Maintains Buy Rating",
        "description": "",
        "summary": "L3Harris Technologies Inc. (NYSE:LHX) is one of the best defense stocks in Goldman Sachs’ portfolio. On October 15, Truist Securities raised its price target on L3Harris Technologies (NYSE:LHX) to $353 from $302, while maintaining a Buy rating ahead of the sector’s third-quarter earnings season. The firm notes that the demand environment and broader sentiment for the […]",
        "pubDate": "2025-10-21T09:36:51Z",
        "displayTime": "2025-10-21T09:36:51Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/f9295a150e11213b051abf0d8649b3b6",
          "originalWidth": 1920,
          "originalHeight": 1118,
          "caption": "Truist Raises L3Harris Technologies' (LHX) Price Target to $353, Maintains Buy Rating",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RvvT3OjNNTbKOWaL0_YkBw--~B/aD0xMTE4O3c9MTkyMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/f9295a150e11213b051abf0d8649b3b6.cf.webp",
              "width": 1920,
              "height": 1118,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Iz_SvejmVeauaZP7EYidhA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/f9295a150e11213b051abf0d8649b3b6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/truist-raises-l3harris-technologies-lhx-093651659.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/truist-raises-l3harris-technologies-lhx-093651659.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LHX"
            },
            {
              "symbol": "TFC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-21T03:08:44+00:00",
    "headline": "Truist Lowers PT on Vericel Corporation (VCEL) to $41 From $46",
    "summary": "Vericel Corporation (NASDAQ:VCEL) is one of the best small cap stocks with the highest upside. On October 15, Truist lowered the price target on Vericel Corporation (NASDAQ:VCEL) to $41 from $46 while keeping a Buy rating on the shares. The rating update was released as part of a broader research note that previewed Q3 results […]",
    "url": "https://finance.yahoo.com/news/truist-lowers-pt-vericel-corporation-030844441.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "28e62aef-117f-3c45-9325-a1f04e9f1e4c",
      "content": {
        "id": "28e62aef-117f-3c45-9325-a1f04e9f1e4c",
        "contentType": "STORY",
        "title": "Truist Lowers PT on Vericel Corporation (VCEL) to $41 From $46",
        "description": "",
        "summary": "Vericel Corporation (NASDAQ:VCEL) is one of the best small cap stocks with the highest upside. On October 15, Truist lowered the price target on Vericel Corporation (NASDAQ:VCEL) to $41 from $46 while keeping a Buy rating on the shares. The rating update was released as part of a broader research note that previewed Q3 results […]",
        "pubDate": "2025-10-21T03:08:44Z",
        "displayTime": "2025-10-21T03:08:44Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/e3c3f86e9fe374c2d88328188aef12c5",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Vericel Corporation (VCEL): Among Stocks with Insanely High PE Ratios Insiders Are Selling",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DaVGljWUNPizZcybgQgUFg--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/e3c3f86e9fe374c2d88328188aef12c5.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5ivfQSj.T32ktsWIm6XVSQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/e3c3f86e9fe374c2d88328188aef12c5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/truist-lowers-pt-vericel-corporation-030844441.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/truist-lowers-pt-vericel-corporation-030844441.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "VCEL"
            },
            {
              "symbol": "TFC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-21T03:08:40+00:00",
    "headline": "Truist Lowers PT on PROCEPT BioRobotics Corporation (PRCT) to $50 From $64, Keeps a Buy Rating",
    "summary": "PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is one of the best small cap stocks with the highest upside. On October 15, Truist slashed the price target on PROCEPT BioRobotics Corporation (NASDAQ:PRCT) to $50 from $64 while maintaining a Buy rating on the shares. The rating update came as part of a broader research note previewing the fiscal […]",
    "url": "https://finance.yahoo.com/news/truist-lowers-pt-procept-biorobotics-030840922.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "53bdd2fe-ebef-343c-849e-f65225d3c055",
      "content": {
        "id": "53bdd2fe-ebef-343c-849e-f65225d3c055",
        "contentType": "STORY",
        "title": "Truist Lowers PT on PROCEPT BioRobotics Corporation (PRCT) to $50 From $64, Keeps a Buy Rating",
        "description": "",
        "summary": "PROCEPT BioRobotics Corporation (NASDAQ:PRCT) is one of the best small cap stocks with the highest upside. On October 15, Truist slashed the price target on PROCEPT BioRobotics Corporation (NASDAQ:PRCT) to $50 from $64 while maintaining a Buy rating on the shares. The rating update came as part of a broader research note previewing the fiscal […]",
        "pubDate": "2025-10-21T03:08:40Z",
        "displayTime": "2025-10-21T03:08:40Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/09e33548435eac227dfb365e9c63cb14",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Is Serve Robotics Inc. (SERV) the Best AI Stock to Buy Under $10?",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_hGBg8fkZ25GWuf2IdcYwA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/09e33548435eac227dfb365e9c63cb14.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LPy2HVQvj9whVh.T7tIIdw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/09e33548435eac227dfb365e9c63cb14.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/truist-lowers-pt-procept-biorobotics-030840922.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/truist-lowers-pt-procept-biorobotics-030840922.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PRCT"
            },
            {
              "symbol": "TFC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-21T03:08:33+00:00",
    "headline": "Janux Therapeutics (JANX) Gets Initiated With a Buy Rating at Truist Financial",
    "summary": "Janux Therapeutics, Inc. (NASDAQ:JANX) is one of the best small cap stocks with the highest upside. Janux Therapeutics, Inc. (NASDAQ:JANX) was initiated with a Buy rating at Truist Financial on October 7. The firm assigned a $100 price target to the stock and cited its proprietary platforms, TRACTr and TRACIr, stating that it believes them […]",
    "url": "https://finance.yahoo.com/news/janux-therapeutics-janx-gets-initiated-030833833.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "90089833-6a72-3ad5-b5b0-d51c5d361a62",
      "content": {
        "id": "90089833-6a72-3ad5-b5b0-d51c5d361a62",
        "contentType": "STORY",
        "title": "Janux Therapeutics (JANX) Gets Initiated With a Buy Rating at Truist Financial",
        "description": "",
        "summary": "Janux Therapeutics, Inc. (NASDAQ:JANX) is one of the best small cap stocks with the highest upside. Janux Therapeutics, Inc. (NASDAQ:JANX) was initiated with a Buy rating at Truist Financial on October 7. The firm assigned a $100 price target to the stock and cited its proprietary platforms, TRACTr and TRACIr, stating that it believes them […]",
        "pubDate": "2025-10-21T03:08:33Z",
        "displayTime": "2025-10-21T03:08:33Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/ec80a372c48a887868cfdcb560576b17",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Janux Therapeutics, Inc. (JANX): Among Unknown Billionaire Phill Gross’ Stock Picks with Huge Upside Potential",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_DaceMZzU88rsX_yOAxVdw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/ec80a372c48a887868cfdcb560576b17.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8U5ZS4grQvGiNvzKWWKWoQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/ec80a372c48a887868cfdcb560576b17.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/janux-therapeutics-janx-gets-initiated-030833833.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/janux-therapeutics-janx-gets-initiated-030833833.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JANX"
            },
            {
              "symbol": "TFC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]